Pharmacokinetics and pharmacodynamics of ranitidine in renal impairment

European Journal of Clinical Pharmacology

Volumn 52, Issue 3, 1997, Pages 229-234

  Koch, K M ^a   Liu, M ^a   Davis, I M ^a   Shaw, S ^a   Yin, Y ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Pharmacodynamics; Pharmacokinetics; Ranitidine; Renal impairment; dose adjustment

Indexed keywords

RANITIDINE;

ADULT; AGED; ARTICLE; BOLUS INJECTION; CLINICAL ARTICLE; CREATININE CLEARANCE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG TOLERANCE; DRUG URINE LEVEL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CLEARANCE; KIDNEY FUNCTION; MALE; PRIORITY JOURNAL; STOMACH PH;

ADULT; AGED; FEMALE; HISTAMINE H2 ANTAGONISTS; HUMANS; KIDNEY DISEASES; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; RANITIDINE; REGRESSION ANALYSIS;

EID: 0030960122     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050279     Document Type: Article

References (10)

1. Grant SM, Langtry HD, Brogden RN (1989) Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases. Drugs 37: 801-870
2. Cross DM (1991) A consideration of the enzymology underlying ranitidine metabolism and drug interactions. J Biopharm Sci 2: 339-377
3. Zech PY, Chau NP, Pozet N, Labeeuw M, Hadj-Aissa A (1983) Ranitidine kinetics in chronic renal impairment. Clin Pharmacol Ther 34: 667-672
4. Meffin PJ, Grgurinovich N, Brooks PM, Miners JO, Cochran M, Stranks G (1983) Ranitidine disposition in patients with renal impairment. Br J Clin Pharmacol 16: 731-734
5. Garg DC, Baltodano N, Jallad NS, Perez G, Oster JR, Eshelman FN, Weidler DJ (1986) Pharmacokinetics of ranitidine in patients with renal failure. J Clin Pharmacol 26: 286-291
6. McFayden ML, Folb PI, Miller R, Keeton GR, Marks IN (1983) Pharmacokinetics of ranitidine in patients with chronic renal failure. Eur J Clin Pharmacol 25: 347-351
7. Dixon JS, Borg-Costanzi LM, Langley SJ, Lacey LF, Toon S (1994) The effect of renal function on the pharmacokinetics of ranitidine. Eur J Clin Pharmacol 46: 167-171
8. Sheiner LB, Stanski DR, Vozeh S, Miller RD, Ham J (1979) Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocuranne. Clin Pharmacol Ther 25: 358-371
9. 2-receptor antagonists. Ann Pharmacother 27: 1532-1537
10. Wormsley KG (1993) Safety profile of ranitidine. A review. Drugs 46: 976-985